See more : 4DMedical Limited (FDMDF) Income Statement Analysis – Financial Results
Complete financial analysis of Solventum Corporation (SOLV) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Solventum Corporation, a leading company in the Medical – Care Facilities industry within the Healthcare sector.
- Telenor ASA (TEL.OL) Income Statement Analysis – Financial Results
- Acceler8 Ventures Plc (AC8.L) Income Statement Analysis – Financial Results
- Cang Bao Tian Xia International Art Trade Center, Inc. (TXCB) Income Statement Analysis – Financial Results
- FHT Future Technology Ltd (FHTF) Income Statement Analysis – Financial Results
- Camplify Holdings Limited (CHL.AX) Income Statement Analysis – Financial Results
Solventum Corporation (SOLV)
About Solventum Corporation
Solventum Corporation, a healthcare company, engages in the developing, manufacturing, and commercializing a portfolio of solutions to address critical customer and patient needs. It operates through four segments: Medsurg, Dental Solutions, Health Information Systems, and Purification and Filtration. The Medsurg segment is a provider of solutions including advanced wound care, I.V. site management, sterilization assurance, temperature management, surgical supplies, stethoscopes, and medical electrodes. The Dental Solutions segment provides a comprehensive suite of dental and orthodontic products including brackets, aligners, restorative cements, and bonding agents. The Health Information Systems provides software solutions including computer-assisted, physician documentation, direct-to-bill and coding automation, classification methodologies, speech, recognition, and data visualization platforms. The Purification and Filtration segment provides purification and filtration technologies including filters, purifiers, cartridges, and membranes. The company was incorporated in 2023 and is based in Saint Paul, Minnesota.
| Metric | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|
| Revenue | 8.20B | 8.13B | 8.17B | 7.28B |
| Cost of Revenue | 3.50B | 3.44B | 3.25B | 2.97B |
| Gross Profit | 4.69B | 4.70B | 4.92B | 4.32B |
| Gross Profit Ratio | 57.25% | 57.75% | 60.25% | 59.26% |
| Research & Development | 758.00M | 767.00M | 766.00M | 719.00M |
| General & Administrative | 0.00 | 0.00 | 0.00 | 0.00 |
| Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 2.24B | 2.24B | 2.28B | 2.17B |
| Other Expenses | 0.00 | -1.00M | 3.00M | 10.00M |
| Operating Expenses | 3.00B | 3.00B | 3.04B | 2.89B |
| Cost & Expenses | 6.51B | 6.44B | 6.29B | 5.85B |
| Interest Income | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Expense | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation & Amortization | 561.00M | 578.00M | 597.00M | 599.00M |
| EBITDA | 2.25B | 2.27B | 2.48B | 2.03B |
| EBITDA Ratio | 27.44% | 27.93% | 30.30% | 27.87% |
| Operating Income | 1.69B | 1.69B | 1.88B | 1.43B |
| Operating Income Ratio | 20.64% | 20.82% | 23.00% | 19.64% |
| Total Other Income/Expenses | -25.00M | -1.00M | 3.00M | 10.00M |
| Income Before Tax | 1.67B | 1.69B | 1.88B | 1.44B |
| Income Before Tax Ratio | 20.34% | 20.81% | 23.03% | 19.78% |
| Income Tax Expense | 321.00M | 349.00M | 422.00M | 302.00M |
| Net Income | 1.35B | 1.34B | 1.46B | 1.14B |
| Net Income Ratio | 16.42% | 16.52% | 17.87% | 15.63% |
| EPS | 7.79 | 7.79 | 8.47 | 6.60 |
| EPS Diluted | 7.79 | 7.79 | 8.47 | 6.60 |
| Weighted Avg Shares Out | 172.71M | 172.47M | 172.47M | 172.47M |
| Weighted Avg Shares Out (Dil) | 172.71M | 172.47M | 172.47M | 172.47M |
Solventum to Participate in the Piper Sandler Healthcare Conference
SOLV Stock Falls Despite Launch of Clarity Precision Grip Attachments
Solventum Launches First 3D Printed Aligner Attachments to Revolutionize Aligner Treatment
Solventum Corporation (SOLV) Q3 2024 Earnings Call Transcript
SOLV Stock Gains as Q3 Earnings & Sales Beat Estimates, '24 View Up
Solventum raises annual profit forecast on strong surgical product sales
Solventum Reports Third Quarter 2024 Financial Results and Raises Full-Year Guidance
Solventum Q3 Earnings Likely to Reflect Declining Volume Trend
Why Investors Need to Take Advantage of These 2 Medical Stocks Now
Solventum Taps Bankers to Explore Sale of Filtration Unit
Source: https://incomestatements.info
Category: Stock Reports